Hyperleptinemia contributes to antipsychotic drug–associated obesity and metabolic disorders is a research paper published in Science Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: R01 DK055758
NIDDK NIH HHS
Grant: R01 DK117872
NIDDK NIH HHS
Grant: R01 DK127274
NIDDK NIH HHS
Grant: R01 DK131537
NIDDK NIH HHS
Grant: R01 DK136532
NIDDK NIH HHS
Grant: RC2 DK118620
NIA NIH HHS
Grant: R00 AG068239
NIDDK NIH HHS
Grant: R01 DK099110
NIDDK NIH HHS
Grant: R01 DK130892
NIDDK NIH HHS
Grant: R01 DK138035
NIA NIH HHS
Grant: P01 AG051459
NIDDK NIH HHS
Grant: R01 DK114036
NIDDK NIH HHS
Grant: P30 DK127984
NIDDK NIH HHS
Grant: R01 DK088423
NIDDK NIH HHS
Grant: R01 DK136619
NIDDK NIH HHS
Grant: R01 DK118725
FWCI
3.52
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals